Integrated analysis of the prognostic and immunotherapeutic significance of ZEB1-AS1 in hepatocellular carcinoma
Abstract Background: Zinc finger E-box binding homeobox 1 antisense 1 (ZEB1-AS1) is a long non-coding RNA (lncRNA) related to the progression of several malignancies and a regulator of oncogenesis in several cancers. Therefore, the aim of our study was to explore the prognostic value and immune relevance of ZEB1-AS1 in hepatocellular carcinoma (HCC). Methods: In this study, a comprehensive investigation integrating bioinformatic analysis and in vitro experiments was conducted to evaluate the role of ZEB1-AS1 in HCC. HCC-related datasets were
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in
